经FDA批准的药物
The U.S. Food and Drug Administration(FDA) is the U.S. federal regulatory agency responsible for supervising the safety of foods, medications, vaccines, medical devices, electromagnetic radiation emitting devices, cosmetics, animal and veterinary products, and tobacco products. In particular, it regulates the approval of new drugs before they hit the market.
The library of medications approved by FDA consists of 1004 molecules.
Related terms: H1 receptor, D2 receptor, Kv11.1, carbonic anhydrase, 5-HT2A receptor, acetylcholinesterase, COX-1, epidermal growth factor receptor, COX-2, D3 receptor
下载PDF文件
Highlights
Viloxazine is a selective norepinephrine reuptake inhibitor. It is indicated for the treatment of clinical depression.
Remdesivir is a nucleoside analog used to treat RNA virus infections.
Risdiplam is an orally bioavailable mRNA splicing modifier used for the treatment of spinal muscular atrophy
Product Features
FDA Approved Drugs Library is a set of 1004 bioactive molecules for HTS/HCS programs.
Comprehensive documentation with structures, trivial names, synonyms, activity coefficient values, types of action on target and references to original literature.
NMR and LCMS validated purity.
All the compounds are available in stock for hit follow-up.
The library is continuously updated.
Product Details
Format: 10 - 100 µL of 10 mM DMSO stock solutions; dry powders (1 mg);
Container: 384-well microplates;
Storage: - 18 °C;
Shipping: Dry ice.
Utility
High throughput screening (HTS);
High content screening (HCS);
Cherry picking.
